NOV 30, 2015 01:10 PM PST

New Test Finds Hidden Pancreatic Cancer Cells, Improves Treatment

WRITTEN BY: Xuan Pham
Pancreatic cancer has one of the worst mortality rates of all cancer types, largely because the cancer spreads rapidly and is seldom detected in its early stages. But researchers at the University of Chicago have found that sampling blood from the portal vein is more sensitive at detecting the cancer’s presence. This method may help doctors to diagnose pancreatic cancer earlier, providing a means to increase prognosis for this disease.
 
Blood taken from the portal vein detects higher tumor cell counts.

In the recent years, scientists have known that tumors can shed cancerous cells from the primary site into the patient’s bloodstream. They call these circulating tumor cells (CTCs), and have leveraged CTC’s presence to create detection methods for a wide range of cancers. Currently, the detection method for pancreatic cancer relies on blood taken from traditional arm venipunctures. However, researchers at the University of Chicago have challenged the sensitivity of this method.

The researchers reasoned that because of the large and irregular shape of CTCs, these cells can get trapped in small vessels before showing up in the bloodstream. So they devised a collection method where blood was taken from the portal vein, the main vessel that drains blood from the gastrointestinal tract and spleen to the liver. Compared to blood taken from the arm, portal vein blood showed much higher sensitivity at detecting tumor cell counts.

"This is a novel and far more sensitive way to acquire, enumerate, and characterize CTCs from pancreatobiliary and other gastrointestinal cancers in this setting.” Dr. Irving Waxman, senior study author.

 In 18 patients with suspected tumors in the pancreas and bile ducts, portal vein sampling detected CTCs for all 100% of patients. In contrast, tumor cells were only detected for 22% of patients with the traditional peripheral blood sampling method. Additionally, they found that the portal vein contained an abundance of CTCs for all cancer stages, including the hard-to-detect early stages. For every 7.5 milliliters of blood, more than 100 tumor cells were detected with portal vein blood samples, compared ~ 1 tumor cell for peripheral blood samples.

This new sampling method will be especially beneficial for early diagnosis of pancreatic cancer. According to the National Cancer Institute, the five-year survival rate for pancreatic cancer is only 7.2%. The disease is so deadly because signs and symptoms don’t appear until the cancer is quite advanced. By such point, the cancer has likely metastasized and surgical removal is not effective. However, with this method, the cancer can be detected early enough where removal is still possible.

"In the setting of localized cancer where these findings are most applicable, the additional information of portal vein CTC number and their molecular characterization may help predict who will benefit from aggressive therapy before surgery, who is most at risk for a recurrence after the operation, and even who will not benefit from surgery at all." Dr. Daniel Catenacci, co-first author of the study.

Watch the video to learn more about pancreatic cancer.
 

Sources: Gastroenterology, Science Daily
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
APR 24, 2018
Cancer
APR 24, 2018
CAR-T Cell Therapy 101
Chimeric antigen receptor T cells (CAR-T cells) have emerged as a useful tool for cancer treatments in a small number of cancers thus far. This area of treatment research is expanding rapidl...
MAY 20, 2018
Clinical & Molecular DX
MAY 20, 2018
EEG Helps Determine the Right Depression Treatment
Scientists want to find effective treatments for mental health disorders, by looking to physiological markers of health and disease....
MAY 30, 2018
Cell & Molecular Biology
MAY 30, 2018
Diagnosing Deadly Kidney Cancers Sooner
Researchers have found that deadly kidney cancers can be identified by assessing their evolutionary path, which is different for distinct types....
JUN 07, 2018
Clinical & Molecular DX
JUN 07, 2018
Digital Screening Vital for Detecting Breast Cancer
A combination of two digital techniques could be the best way to diagnose breast cancer. In a new study, scientists show how combining a technique called t...
JUN 16, 2018
Videos
JUN 16, 2018
What is Preimplantation Genetic Diagnosis?
All parents want a healthy baby, and for some people that carry genetic mutations, the decision to have children presents a challenge....
JUN 20, 2018
Genetics & Genomics
JUN 20, 2018
The Cause of a Rare Neurological Disease is Identified
In a recent study, scientists sequenced the genome to find the mutation behind a disorder that causes blindness and paralysis....
Loading Comments...